Filing Details

Accession Number:
0001562180-20-005448
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-14 18:27:13
Reporting Period:
2020-01-27
Accepted Time:
2020-08-14 18:27:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1459839 Si-Bone Inc. SIBN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296771 Gordon John Freund C/O Skyline Ventures
525 University Avenue, Suite 1350
Palo Alto CA 94301
No No No No
1419187 Skyline Venture Partners V Lp 525 University Avenue, Suite 1350
Palo Alto CA 94301
No No No No
1434887 Skyline Venture Management V, Llc 525 University Avenue, Suite 1350
Palo Alto CA 94301
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-27 1,000,000 $21.50 2,819,985 No 4 S Indirect By Skyline Venture Partners V, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Skyline Venture Partners V, LP
Footnotes
  1. Shares are sold in the conjunction with SI-BONE, INC's public offering of common stock announced on January 21st, 2020.
  2. Shares held by Skyline Venture Partners V, L.P. ("SVP V"). Skyline Venture Management V, LLC ("LLC") is the general partner of SVP V and as such may be deemed to have voting and investment power with respect to the securities of SVP V. Dr. Freund, a member of the Issuer's board of directors, is a managing director of LLC and may be deemed to have voting and investment power with respect to the securities held by SVP V. Dr. Freund disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein. Although each of SVP V and LLC have ceased to be subject to the reporting requirements of Section 16 as a result of this sale of shares and the public offering, Dr. Freund is a director of SI-BONE, Inc. and, accordingly, remains subject to the reporting requirements of Section 16.